The way in which the FDA plans to pass along drug safety information to the public has been finalized in the guidance Drug Safety InformationFDA's Communication to the Public. According to the agency, the document is intended to ensure that emerging drug safety information is available in a balanced, impartial manner so that healthcare professionals and patients can consider the information when making decisions about medical treatments, despite uncertainties in the data. The various methods to be utilized include Public Health Advisories, Patient Information Sheets, Healthcare Professional Sheets, and Alerts on Patient Information. The new guidance also describes the role of the Drug Safety Oversight Board. The FDA's safety postings can be accessed at
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Improved Understanding of Hidradenitis Suppurativa Can Enhance Patient Outcomes
July 14th 2025Researchers assessed the difference between hidradenitis suppurativa and other skin conditions regarding the initiating events, inflammatory signature, and molecular and clinical features of each disease.